Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share


Therapeutic Areas: Oncology | Otolaryngology (Ear, Nose, Throat) | Family Medicine

Head and Neck Cancer Clinical Trials


A listing of Head and Neck Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Scottsdale : 21st Century Oncology

Squamous Cell Carcinoma

View More »

Scottsdale :

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Arkansas

Fayetteville : Highlands Oncology Group Updated

A Phase 2 clinical study for patients with Head and Neck Neoplasms

California

San Diego : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Los Angeles : University of Southern California

A clinical study for patients with Cystic Fibrosis

Los Angeles : UCLA Hematology-Oncology Clinic Updated

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

San Francisco : University of California, San Francisco

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

Stanford : Stanford University

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Connecticut

New Haven :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

District of Columbia

Washington : Georgetown Lombardi Comprehensive Cancer Center

A clinical research study of Nilotinib + Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Florida

Tampa : Moffitt Cancer Center Updated

A clinical trial to evaluate treatments using MGA271 for patients

Tampa :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Georgia

Savannah : Memorial University Medical Center

ECOG E1305: A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.

Savannah : Memorial University Medical Center

RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer.

Savannah : Memorial University Medical Center

RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Savannah : Memorial University Medical Center

RTOG 1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Illinois

View More »

Chicago : The University of Chicago Medical Center

A clinical research study of Everolimus escalating dose and Everolimus or Placebo for the treatment of Head and Neck Cancer

Chicago : Northwestern University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Chicago : The University of Chicago Medical Center

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Chicago : University of Illinois-Chicago

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Chicago : The University of Chicago Updated

A clinical trial to evaluate treatments using MGA271 for patients

Chicago : University Of Chicago

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Harvey : Ingalls Cancer Research Center

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Iowa

Iowa City : Holden Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Head and Neck Neoplasms

Kansas

Fairway : University of Kansas Medical Center

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Kansas City : University of Kansas

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Louisiana

Shreveport : Louisianna State University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Maryland

Baltimore : University of Maryland Greenebaum Cancer Center

Patients are needed to participate in a clinical research study evaluating Reirradiation and MK-3475 for the treatment of Recurrent Head and Neck Cancer or Carcinoma, Squamous Cell of Head and Neck

Baltimore : Johns Hopkins University

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Baltimore :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Massachusetts

Boston : Mirati Research Site

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Boston : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Boston : Dana Farber Cancer Institute Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Boston : Tufts Medical Center

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Boston : Dana Farber Cancer Institute Updated

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Massachusetts General Hospital Cancer Center Updated

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Massachusetts General Hospital Updated

A Phase 1/1b clinical study for patients with Advanced Cancer

Boston : Dana-Farber Cancer Institute

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Boston :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Boston :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Michigan

Detroit : Henry Ford Health System

Squamous Cell Carcinoma

View More »

Ann Arbor : University of Michigan

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Minnesota

Minneapolis : University of Minnesota - Cystic Fibrosis Center

A clinical study for patients with Cystic Fibrosis

Minneapolis : University of Minnesota

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Mississippi

View More »

Jackson : University of Mississippi

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Missouri

St. Louis : Mirati Research Site

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

St. Louis : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

St. Louis : Washington University School of Medicine

A clinical research study of nab-paclitaxel, Cisplatin, Carboplatin and Cetuximab for the treatment of Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma or Cancer of the Head and Neck

St. Louis : Washington University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

St. Louis : Washington University Center for Advanced Medicine Updated

A Phase 1/1b clinical study for patients with Advanced Cancer

St. Louis : Washington University School of Medicine Updated

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Nevada

Las Vegas :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Reno : VA Sierra Nevada Health Care System Updated

A Phase 2 clinical study for patients with Head and Neck Neoplasms

New Jersey

New York

Bronx : Biomedical Research Alliance of New York

Head and Neck Cancer, Melanoma, and Other Superficial Cancers

New York : Mirati Research Site

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

View More »

Albany :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

New York : Icahn School of Medicine at Mount Sinai

A clinical research study of ADXS11-001 (ADXS-HPV) for the treatment of Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck or Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

New York : Columbia University Updated

A Phase 1/1b clinical study for patients with Advanced Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

North Carolina

Durham : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Greenville : 21st Century Oncology

Squamous Cell Carcinoma

View More »

Chapel Hill : University of North Carolina at Chapel Hill

A clinical research study of Cetuximab, Nab-paclitaxel and Carboplatin for the treatment of Head and Neck Cancer

Chapel Hill : University of North Carolina

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Chapel Hill : The University of North Carolina at Chapel Hill

A Phase 2 clinical study for patients with Head and Neck Cancer or Squamous Cell Carcinoma of the Head and Neck

Chapel Hill : University of North Carolina Updated

A Phase 2 clinical study for patients with Head and Neck Neoplasms

Huntersville : Carolina Biooncology Institute Updated

A clinical trial to evaluate treatments using MGA271 for patients

Huntersville :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Ohio

Columbus : Ohio State University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Oregon

Portland : Providence Portland Medical Center Updated

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Portland : Providence Oncology & Hematology Care Eastside

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Portland : Portland VA Medical Center

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Pennsylvania

Philadelphia : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center Updated

A clinical trial to evaluate treatments using MGA271 for patients

Pittsburgh : Upmc Cancer Center

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

South Carolina

Charleston : Medical University of South Carolina Hollings Cancer Center

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Charleston : Medical University of South Carolina

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Tennessee

Nashville : Mirati Research Site

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

View More »

Nashville : Vanderbilt University

A clinical research study of Cetuximab, Nab-paclitaxel and Carboplatin for the treatment of Head and Neck Cancer

Nashville : Sarah Cannon Research Institute Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Nashville : Vanderbilt University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Nashville : Sarah Cannon Research Institute Updated

A clinical trial to evaluate treatments using MGA271 for patients

Nashville : Sarah Cannon Research Institute Updated

A Phase 1/1b clinical study for patients with Advanced Cancer

Nashville :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Nashville :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Texas

Houston : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Galveston : The University of Texas Medical Branch at Galveston

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments for patients with Head and Neck Cancer or Squamous Cell Carcinoma of the Head and Neck

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Cetuximab, IMC-A12 and Surgical tumor resection for patients with Head and Neck Squamous Cell Carcinoma

Houston : University of Texas MD Anderson

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

San Antonio : South Texas Accelerated Research Therapeutics Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Utah

Salt Lake City : Mirati Research Site New

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Salt Lake City : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Salt Lake City : University of Utah

A clinical study for patients with Cystic Fibrosis

Salt Lake City : The Huntsman Cancer Institute Updated

A Phase 1/1b clinical study for patients with Advanced Cancer

Virginia

Norfolk :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Washington

Seattle : University of Washington

A clinical research study of Cetuximab, Nab-paclitaxel and Carboplatin for the treatment of Head and Neck Cancer

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

D4193C00001 - A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Morgantown : West Virginia University - Clinical Trials Research Unit

E1311- A Randomized, Placebo Controlled Phase II Trial of Afatinib (BIBW2992) as Adjuvant Therapy Following Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma at High Risk of Recurrence

Morgantown : West Virginia University - Clinical Trials Research Unit

RTOG-0920 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

Morgantown : West Virginia University - Clinical Trials Research Unit

RTOG1216 - Randomized Phase II/III Trial of Surgery and Postoperavtive Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Austria

Innsbruck : Medical University of Innsbruck, Department for Internal Medicine I

Patients are needed to participate in a clinical research study of Lenalidomide and Cetuximab to evaluate Solid Tumors

Belgium

Bruxelles : Jules Bordet Institute

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bruxelles : Cliniques Universitaires St-Luc, Service d'oncologie médicale

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Edegem :

A clinical trial to evaluate treatments for patients with Head and Neck Cancer

Bosnia

Banja Luka : Clinical Center Banja Luka

Squamous Cell Carcinoma

Canada

Edmonton : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Vancouver : Mirati Research Site

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

London : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

China

Guangzhou : Cancer center, Sun Yat-sen University

A clinical trial seeking patients for a research study for the treatment of Head and Neck Squamous Carcinoma or Nasopharyngeal Carcinoma

Croatia

Osijek : CHC Osijek

Squamous Cell Carcinoma

Zagreb : CH Dubrava

Squamous Cell Carcinoma

Zagreb : KBC Zagreb

Squamous Cell Carcinoma

Zagreb : KBC Sestre Milosrdnice

Squamous Cell Carcinoma

France

Lyon :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Paris : Institut Curie

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer

Toulouse :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Villejuif :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Germany

Berlin :

Patients are needed to participate in a clinical research study evaluating MEHD7945A and cetuximab for the treatment of Head and Neck Cancer

Essen :

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Germany : University of Heidelberg Medical Center

A clinical trial to evaluate treatments using Erbitux® and Fractionated Radiotherapy for patients with Head and Neck Cancer

Heidelberg : University of Heidelberg Medical Center

A clinical research study of ECA and Standard topical treatment of the institution, e.g. Lotio for the treatment of Pain

Würzburg :

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Hungary

Budapest : Uzsoki Hospital

Squamous Cell Carcinoma

Israel

Haifa : Rambam Health Care Campus

Squamous Cell Carcinoma

Tikva : Rabin Medical Center

Squamous Cell Carcinoma

View More »

Tel Aviv : Sourasky Medical Center

Patients are needed to participate in a clinical research study evaluating IZN-6N4 for the treatment of Oral Mucositis

Italy

Milano :

Patients are needed to participate in a clinical research study evaluating MEHD7945A and cetuximab for the treatment of Head and Neck Cancer

Japan

Chubu Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

Chugoku Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

Kanto Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

Kinki Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

Tohoku Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

View More »

Tsu : Mie University Hospital

A clinical trial to evaluate treatments using TBI-1201, Cyclophosphamide and Fludarabine for patients with Solid Tumors

Korea, Republic of

Seoul : Seoul St.Mary's Hospital of the Catholic University of Korea

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer

Seoul :

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Netherlands

Amsterdam : Netherlands Cancer Institute

A Phase 2 clinical study for patients with Head and Neck Cancer

Nijmegen : University Medical Center Nijmegen st Radboud

A Phase 2 clinical study for patients with Head and Neck Cancer

Norway

Oslo : Oslo University Hospital Radiumhospitalet

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Poland

Portugal

Porto : Hospital CUF Porto

Patients are needed to participate in a clinical research study evaluating LUZ11 for the treatment of Head and Neck Cancer

Russia

Moscow : Blokhin Cancer Research Center

Squamous Cell Carcinoma

Serbia

Spain

Barcelona :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Madrid : START MADRID, Hospital Universitario Madrid Norte Sanchinarro

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer

Madrid : START MADRID, Hospital Fundacion Jimenez Diaz

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer

Switzerland

St. Gallen :

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Taiwan

Changua : Changua Christian Hospital

Squamous Cell Carcinoma

Ukraine

United Kingdom

London : Guy's Hospital

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

London :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Papworth Everard : Papworth Hospital NHS Trust

Patients are needed to participate in a clinical research study of Gefitinib to evaluate Lung Cancer or Head and Neck Cancer